Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
94 participants
INTERVENTIONAL
2015-04-30
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Nefopam in Breast Cancer Surgery
NCT02949310
Nefopam as a Multimodal Analgesia for Thoracic Surgery
NCT05173337
The Effects of Anesthetics on Persistent Pain Following Breast Cancer Surgery
NCT03782896
Postoperative Analgesic Effect of Nefopam
NCT02561494
Effect of Nefopam on Acute Postoperative Pain in Patients Undergoing Orthognathic Surgery
NCT01461031
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nefopam
20 mg nefopam in 100 ml normal saline is infused before starting operation.
Nefopam
Control
100 ml normal saline is infused before starting operation.
Saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nefopam
Saline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lumpectomy with axillary lymph node dissection or Lumpectomy with sentinel lymph node biopsy
* American Society of Anesthesiologists physical status I or II
Exclusion Criteria
* Seizure
* Cardiac disease
* Monoamine oxidase inhibitor user
* Urologic disease
* Glucoma
* Preoperative analgesic drug medication
* Pregnancy
* Recurred breast cancer patient
20 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hyo-Seok Na
Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Nefo_breast cancer
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.